10x Genomics(TXG) - 2025 Q4 - Annual Results

Exhibit 99.1 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 PLEASANTON, Calif. February 12, 2026 – 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided its outlook for 2026. Recent Updates "In 2025, our team executed with discipline through a challenging environment while continuing to strengthen the fundamentals of the b ...